Jamshed Kanga, MD

7/1/10 → 6/30/11

Project: Research project

Randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety and efficacy of inhaled ciprofloxacin compared to placebo in subjects with cystic fibrosis

Danov, Z., Anstead, M., Kanga, J., Watts, T. & Tuney, D.

Bayer Corp

6/30/10 → 1/31/12

Project: Research project

Study 08-114: Open-Label Extension of Study 08-110--A Multi-Center Study of Denufosol Tetrasodium Inhalation Solution in Patients with Cystic Fibrosis Lung Disease

Inspire Pharmaceuticals

9/16/09 → 9/30/10

Project: Research project

A Phase 3, 2-Part, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Pharmacokinetics, Efficacy and Safety of VX-770 in Subjects aged 6-11 with Cystic Fibrosis and the G551D Mutation

Vertex Pharmaceuticals Inc

8/26/09 → 8/25/10

Project: Research project

A Phase 3, 2-Part, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Pharmacokinetics, Efficacy and Safety of VX-770 in Subjects with Cystic Fibrosis and the G551D Mutation

Anstead, M. & Kanga, J.

Vertex Pharmaceuticals Inc

8/26/09 → 8/25/10

Project: Research project

Cystic Fibrosis Center Program

Kanga, J., Anstead, M., Danov, Z. & Hayes, D.

7/1/09 → 6/30/10

Project: Research project

The EPIC Observational Study: Effectiveness and Safety of Intermittent Antimicrobial Therapy for the Treatment of New Onset Pseudomonas Aeruginosa (Pa) Airway Infection in Young Patients with Cystic Fibrosis

Seattle Childrens Research Institute

4/1/09 → 3/31/14

Project: Research project

Therapeutics Development Center

1/1/09 → 12/31/12

Project: Research project

Therapeutics Development Center

Kanga, J., Anstead, M., Danov, Z. & Kuhn, R.

1/1/09 → 12/31/13

Project: Research project

Therapeutics Development Center

1/1/09 → 12/31/11

Project: Research project

Therapeutics Development Center

1/1/09 → 12/31/10

Project: Research project

University of Kentucky Therapeutic Development Center

1/1/09 → 12/31/09

Project: Research project

Therapeutics Development Network 2014

Anstead, M., Danov, Z., Kanga, J. & Kuhn, R.

1/1/09 → 12/31/14

Project: Research project

A Phase 3, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Study of Denufosol Tetrasodium Inhalation Solution in Patients with Cystic Fibrosis Lung Disease and FEV, => 75% but =<110% Predicted

Inspire Pharmaceuticals

8/1/08 → 4/30/11

Project: Research project

Cystic Fibrosis Center Program

7/1/08 → 6/30/09

Project: Research project

A Phase III Randomized Double-Blind Placebo-Controlled Clinnical Study Evaluating the Efficacy and Safety of ALTU-135 Treatment in Patients with Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency

Altus Pharmaceuticals Inc.

2/19/08 → 8/31/08

Project: Research project

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Pulmozyme Withdrawal on Exercise Tolerance in Cystic Fibrosis Subjects with Severe Lung Disease

Genentech Inc

8/16/07 → 12/31/09

Project: Research project

Cystic Fibrosis Center Program

7/1/07 → 6/30/08

Project: Research project

A Multicenter, Double-Blind, Palcebo Controlled, Randomized, Efficacy and Safety Study of Denufosol Tetrasodium (INS37217) Inhalation Solution in Patients with Mild Cystic Fibrosis Lung Disease

Inspire Pharmaceuticals

2/1/07 → 7/31/09

Project: Research project

A Multicenter, Randomized, Double-Blind, Crossover Study to Compare the Safety and Efficacy of Ultrase MT20 to Placebo for the Correction of Steatorrhea in Patients with Cystic Fibrosis

Axcan Pharma Inc.

1/1/07 → 12/31/08

Project: Research project

Cystic Fibrosis Research TDN Grant

12/1/06 → 12/31/08

Project: Research project

Cystic Fibrosis Research TDN Grant

12/1/06 → 11/30/07

Project: Research project

Cystic Fibrosis Center Program

7/1/06 → 6/30/07

Project: Research project

Cystic Fibrosis Center Program

7/1/05 → 6/30/06

Project: Research project

The EPIC Observational Study: Longitudinal Assessment of Risk Factors for and Impact of Pseudomonoas Aeruginosa Acquisition and Early Anti-Pseudomonal Treatment in Children with CF

2/1/05 → 9/30/09

Project: Research project

Cystic Fibrosis Center Program

7/1/04 → 6/30/05

Project: Research project

A Phase 2, Randomized, Double Blind, Parallel Dose Ranging Study of Oral TheraCLEC--Total In Cystic Fibrosis Subjects with Exocrine Pancreatic Insufficiency

Altus Pharmaceuticals Inc.

6/1/04 → 8/31/05

Project: Research project

The EPIC Clinical Study: Effectiveness and Safety of Intermittent Antimicrobial Therapy for the Treatment of New Onset Pseudomonas Aeruginosa (Pa) Airway Infection in Young Patients with Cystic Fibrosis

3/1/04 → 9/30/09

Project: Research project

Cystic Fibrosis Center Program

7/1/03 → 6/30/04

Project: Research project

Epidemiologic Study of Cystic Fibrosis: A Multicenter Longitudinal Follow Up Study of Patients with Cystic Fibrosis for Monitoring Pulmonary Function, Pulmonary Exacerbations, and the Safety of Long Term Treatment with Pulmozyme Inhalation Solution

Genentech Inc

1/1/03 → 3/31/06

Project: Research project

Cystic Fibrosis Center Program

7/1/02 → 6/30/03

Project: Research project

Cystic Fibrosis Center Program

7/1/01 → 6/30/02

Project: Research project

Cystic Fibrosis Center Program